Genomic and Clinicopathologic Characterization ofATM-deficient Prostate Cancer
Abstract
The ATM (ataxia telangiectasia mutated) gene is mutated in a subset of prostate cancers, and ATM mutation may confer specific therapeutic vulnerabilities, although ATM-deficient prostate cancers have not been well-characterized.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 15, 2020
- Source ID
- 10.1158/1078-0432.ccr-20-0764
Entities
People
- Angelo M De Marzo
- Bruce J Trock
- Colin C Pritchard
- Daniela C Salles
- Emmanuel S. Antonarakis
- Harsimar Kaur
- Jerry S. Lanchbury
- Jessica Hicks
- Kirsten M. Timms
- Le-Minh Nguyen
- Sanjana Murali
- Tamara L Lotan
- William B Isaacs
Organizations
- Johns Hopkins School of Medicine
- Johns Hopkins University
- National Cancer Institute
- National Institutes of Health
- United States Department of Defense
- University of Washington